What's breaking now, across thousands of outlets.
A US biotech with a slightly different approach to the burgeoning NewCo model has raised another $115 million for its China-sourced COPD drug candidate. Virtual biotech Expedition Therapeutics disclosed the Series B Wednesday morning in ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
A provincial government in Nepal has legalized the use and growing of marijuana for medical purposes despite a national ban.
Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
Narcolepsy is a chronic neurological condition characterized by disruptions in the regulation of sleep-wake cycles. People with this condition often experience extreme sleepiness during the day and, in some cases, a sudden but temporary loss of muscle strength while conscious, called cataplexy.
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.
NeX, which is built on the EnzeneX continuous manufacturing (FCCM) platform, is designed to deliver a turnkey and scalable way to make biologics manufacturing transportable, close to patients and supply chains.
